Internal Medicine · Gadsden, AL
NPI
1467416941
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
311 S 4th St
Gadsden, AL, 35901
Phone (256) 543-9955
Groups this clinician bills Medicare through
Medicare paid, 2024
$227K
4,679 services
Medicare patients, 2024
361
Average age 74
Drug cost, 2024
$2.0M
23,612 prescriptions
Company payments, 2025
$757
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oluwole S Akisanya was code 99231 (hospital e&m - subsequent), 918 times for 80 patients. In total Oluwole S Akisanya billed 4,679 services in 54 codes, and Medicare paid $227K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99231 Hospital E&M - Subsequent | Facility | 918 | 80 | $38.82 | $36K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 694 | 79 | $47.62 | $33K |
| 99457 E&M - Miscellaneous | Office | 415 | 57 | $37.92 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 341 | 95 | $61.99 | $21K |
| 99214 Office E&M - Established | Office | 281 | 112 | $84.72 | $24K |
| 99458 E&M - Miscellaneous | Office | 251 | 51 | $30.90 | $7,756 |
| 99454 E&M - Miscellaneous | Office | 251 | 50 | $34.78 | $8,730 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 228 | 60 | $36.41 | $8,301 |
| 99307 SNF E&M | Office | 143 | 44 | $30.22 | $4,322 |
| 99222 Hospital E&M - Initial | Facility | 142 | 112 | $101.84 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 122 | 26 | $93.09 | $11K |
| 99238 Hospital Discharge Management | Facility | 93 | 72 | $63.55 | $5,910 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 86 | 18 | $0.34 | $29.46 |
| 99213 Office E&M - Established | Office | 82 | 53 | $59.54 | $4,882 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 60 | 60 | $125.94 | $7,557 |
By year: 2022 $159K for 3,337 services; 2023 $137K for 2,622 services; 2024 $227K for 4,679 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 22 | $8.70 | $200 |
Medicare prescription drug claims, 2024
In 2024, the drug Oluwole S Akisanya prescribed most often to Medicare patients was Amlodipine Besylate, with 1,005 prescriptions and refills. In total Oluwole S Akisanya wrote 23,612 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,005 | 1,866 | 239 | $7,657 |
| Carvedilol Generic | 919 | 1,695 | 207 | $7,750 |
| Losartan Potassium Generic | 892 | 1,807 | 239 | $11K |
| Pantoprazole Sodium Generic | 805 | 1,330 | 184 | $9,911 |
| Gabapentin Generic | 715 | 798 | 179 | $8,686 |
| Atorvastatin Calcium Generic | 676 | 1,199 | 156 | $7,977 |
| Levothyroxine Sodium Generic | 558 | 1,098 | 134 | $5,783 |
| Montelukast Sodium Generic | 547 | 1,107 | 157 | $8,015 |
| Tramadol Hcl Generic | 493 | 494 | 140 | $4,066 |
| Furosemide Generic | 476 | 738 | 114 | $2,404 |
| Metformin Hcl Generic | 439 | 894 | 116 | $3,283 |
| Duloxetine Hcl Generic | 381 | 520 | 60 | $8,790 |
| Omeprazole Generic | 371 | 734 | 88 | $5,756 |
| Potassium Chloride Generic | 356 | 489 | 62 | $5,370 |
| Rosuvastatin Calcium Generic | 331 | 911 | 122 | $6,543 |
Brand drugs: 2,778 claims; generic drugs: 20,644 claims; opioid claims: 711.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oluwole S Akisanya $757 ($757 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novo Nordisk Inc with $146.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 2 | $146 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $103 |
| GlaxoSmithKline, LLC. GSK | 4 | $93.24 |
| Lundbeck LLC | 4 | $83.1 |
| Corcept Therapeutics CORT | 2 | $51.04 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $42.13 |
| Boston Scientific Corporation BSX | 2 | $40.74 |
| Abbvie Inc. ABBV | 2 | $35.92 |
| Exact Sciences Corporation EXAS | 1 | $33.84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $25.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.